DA agonists -- ergot derivatives: bromocriptine: management of Parkinson's disease.
D001577:Benzophenones / Q000494:pharmacology / Q000627:therapeutic use; D001971:Bromocriptine / Q000494:pharmacology* / Q000627:therapeutic use*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000494:pharmacology* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D004873:Ergolines / Q000494:pharmacology / Q000627:therapeutic use; D004876:Ergot Alkaloids / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D008090:Lisuride / Q000494:pharmacology / Q000627:therapeutic use; D009596:Nitrophenols; D010300:Parkinson Disease / Q000188:drug therapy*; D010479:Pergolide / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077867:Tolcapone
D001577:Benzophenones; D018491:Dopamine Agonists; D004791:Enzyme Inhibitors; D004873:Ergolines; D004876:Ergot Alkaloids; D009596:Nitrophenols; D010479:Pergolide; D001971:Bromocriptine; D007980:Levodopa; D000077867:Tolcapone; D008090:Lisuride; D000077465:Cabergoline